Unusual pigmentation in patients with AIDS who are receiving rifabutin for bacteremia due to Mycobacterium avium/Mycobacterium intracellulare complex.
Smith
J F
JF
Department of Medicine, Brown University, Providence, Rhode Island, USA.
Flanigan
T P
TP
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000150:complications; D017828:Rifabutin / Q000009:adverse effects* / Q000627:therapeutic use
D017828:Rifabutin